NanoGroup S.A. (NNG.WA)

PLN 3.12

(-4.59%)

Operating Income Summary of NanoGroup S.A.

NanoGroup S.A.'s latest annual operating income in 2023 was -7.9 Million PLN , down -910.29% from previous year.
NanoGroup S.A.'s latest quarterly operating income in 2024 Q2 was -1.35 Million PLN , down -4.32% from previous quarter.
NanoGroup S.A. reported an annual operating income of -782.14 Thousand PLN in 2022, up 74.55% from previous year.
NanoGroup S.A. reported an annual operating income of -3.07 Million PLN in 2021, up 5.83% from previous year.
NanoGroup S.A. reported a quarterly operating income of -1.29 Million PLN for 2024 Q1, up 55.68% from previous quarter.
NanoGroup S.A. reported a quarterly operating income of -1.48 Million PLN for 2023 Q3, up 9.77% from previous quarter.

Annual Operating Income Chart of NanoGroup S.A. (2023 - 2015)

Historical Annual Operating Income of NanoGroup S.A. (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	-7.9 Million PLN	-910.29%
2022	-782.14 Thousand PLN	74.55%
2021	-3.07 Million PLN	5.83%
2020	-3.26 Million PLN	-90.98%
2019	-1.7 Million PLN	28.95%
2018	-2.4 Million PLN	-19.45%
2017	-2.01 Million PLN	-111.74%
2016	-951 Thousand PLN	-49.91%
2015	-634.38 Thousand PLN	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-1.35 Million PLN	-4.32%
2024 Q1	-1.29 Million PLN	55.68%
2023 Q3	-1.48 Million PLN	9.77%
2023 Q1	-1.84 Million PLN	-159.22%
2023 Q2	-1.64 Million PLN	10.68%
2023 FY	-16.63 Million PLN	-2026.61%
2023 Q4	-2.92 Million PLN	-96.5%
2022 Q2	-867.67 Thousand PLN	-172943.94%
2022 FY	-782.14 Thousand PLN	74.55%
2022 Q4	3.11 Million PLN	330.08%
2022 Q3	-1.35 Million PLN	-56.05%
2022 Q1	502.00 PLN	-99.94%
2021 Q1	21.00 PLN	100.0%
2021 Q2	-2.71 Million PLN	-12936378.43%
2021 FY	-3.07 Million PLN	5.83%
2021 Q3	2.71 Million PLN	200.0%
2021 Q4	788.61 Thousand PLN	-70.97%
2020 Q2	-807.6 Thousand PLN	-11412.59%
2020 Q1	7139.00 PLN	100.37%
2020 FY	-3.26 Million PLN	-90.98%
2020 Q4	-5.41 Million PLN	-660.89%
2020 Q3	965.82 Thousand PLN	219.59%
2019 Q2	-599.75 Thousand PLN	-857.72%
2019 Q1	79.15 Thousand PLN	103.13%
2019 FY	-1.7 Million PLN	28.95%
2019 Q3	719.61 Thousand PLN	219.98%
2019 Q4	-1.9 Million PLN	-365.09%
2018 Q2	-1.71 Million PLN	-6984.37%
2018 Q3	1.81 Million PLN	205.84%
2018 FY	-2.4 Million PLN	-19.45%
2018 Q4	-2.53 Million PLN	-239.33%
2018 Q1	24.92 Thousand PLN	103.22%
2017 Q2	-934.62 Thousand PLN	-2038.73%
2017 FY	-2.01 Million PLN	-111.74%
2017 Q3	-353.23 Thousand PLN	62.21%
2017 Q1	48.2 Thousand PLN	0.0%
2017 Q4	-774.04 Thousand PLN	-119.13%
2016 FY	-951 Thousand PLN	-49.91%
2015 FY	-634.38 Thousand PLN	0.0%

Peer Operating Income Comparison of NanoGroup S.A.

Name	Operating Income	Operating Income Difference
Bioceltix S.A.	-15.81 Million PLN	50.05%
BIOTON S.A.	15.29 Million PLN	151.663%
Captor Therapeutics Spolka Akcyjna	-73.01 Million PLN	89.178%
Mabion S.A.	55.06 Million PLN	114.351%
Molecure S.A.	-22.1 Million PLN	64.251%
Pharmena S.A.	34.87 Million PLN	122.66%
Poltreg S.A.	-16.86 Million PLN	53.138%
Pure Biologics Spólka Akcyjna	-31.71 Million PLN	75.087%
Ryvu Therapeutics S.A.	-100.94 Million PLN	92.172%
Synthaverse S.A.	8.64 Million PLN	191.383%
Urteste S.A.	-6.44 Million PLN	-22.567%